This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adam, M.A., Ramesh, N., Miller, A.D., and Osborne, W.R., (1991), Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions, J Virol65:4985–4990.
Arai, T., Matsumoto, K., Saitoh, K., Ui, M., Ito, T., Murakami, M., Kanegae, Y., Saito, I., Cosset, F.L., Takeuchi, Y., and Iba, H., (1998), A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines, J Virol72:1115–1121.
Bartholomew, R.M., Esser, A.F., and Muller-Eberhard, H.J., (1978), Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E, J Exp Med147:844–853.
Boeke, J.D., and Stoye, J.P., (1997), Retrotransposons, endogenous retroviruses, and the evolution of retroelements, in Retroviruses (J.M. Coffin, S.H. Hughes, and H.E. Vermus eds.) pp. 343–436, Cold Spring Harbor Laboratory Press, New York.
Burns, J.C., Friedmann, T., Driever, W., Burrascano, M., and Yee, J.K., (1993), Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells, Proc Natl Acad Sci U S A90:8033–8037.
Cepko, C.L., Roberts, B.E., and Mulligan, R.C., (1984), Construction and applications of a highly transmissible murine retrovirus shuttle vector, Cell37:1053–1062.
Chakraborty, A.K.., Zink, M.A., and Hodgson, C.P., (1994), Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy, Cancer Gene Ther1:113–118.
Chen, ST., Iida, A., Guo, L., Friedmann, T., and Yee, J.K., (1996), Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system, Proc Natl Acad Sci U S A93:10057–10062.
Chong, H., Starkey, W., and Vile, R.G., (1998), A replication-competent retrovirus arising from a splitfunction packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences, J Virol72:2663–2670.
Chong, H., and Vile, R.G., (1996), Replication-competent retrovirus produced by a “split-function” third generation amphotropic packaging cell line, Gene Ther3:624–629.
Choulika, A., Guyot, V, and Nicolas, J.F., (1996), Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site, J Virol70:1792–1798.
Chu, T.H., and Dornburg, R., (1995), Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer, J Virol69:2659–2663.
Chu, T.H., and Dornburg, R., (1997), Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies, J Virol71:720–725.
Chu, T.H., Martinez, I., Sheay, W.C., and Dornburg, R., (1994), Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins, Gene Ther1:292–299.
Collins, M., and Porter, C, (1998), Retroviral vectors, in Blood Cell Biochemistry. Volume 8: Hematopoiesis and Gene Therapy, (L.J. Fairbairn, and N.G. Testa, eds.) pp. 57–88, Plenum Press.
Cooper, N.R., Jensen, F.C., Welsh, R.M., Jr., and Oldstone, M.B., (1976), Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway, J Exp Med144:970–984.
Cosset, F.L., and Russell, S.J., (1996), Targeting retrovirus entry, Gene Ther3:946–956.
Cosset, F.L., Takeuchi, Y., Battini, J.L., Weiss, R.A., and Collins, M.K., (1995), High-titer packaging cells producing recombinant retroviruses resistant to human serum, J Virol69:7430–7436.
Danos, O., and Mulligan, R.C., (1988), Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges, Proc Natl Acad Sci U S A85:6460–6464.
Diaz, R.M., Eisen, T., Hart, I.R., and Vile, R.G., (1998), Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma, J Virol72:789–795.
Emerman, M., and Temin, H.M., (1984), Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism, Cell39:449–467.
Emerman, M., and Temin, H.M., (1986), Comparison of promoter suppression in avian and murine retrovirus vectors, Nucleic Acids Res14:9381–9396.
Emi, N., Friedmann, T., and Yee, J.K., (1991), Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus, J Virol65:1202–1207.
Etienne-Julan, M., Roux, P., Carillo, S., Jeanteur, P., and Piechaczyk, M., (1992), The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker, J Gen Virol73:3251–3255.
Feng, M., Jackson, W.H., Jr., Goldman, C.K.., Rancourt, C., Wang, M., Dusing, S.K., Siegal, G., and Curiel, D.T., (1997), Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector, Nat Biotechnol15:866–870.
Fernex, C., Dubreuil, P., Mannoni, P., and Bagnis, C., (1997), Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transchption in human hematopoietic cells, J Virol71:7533–7540.
Ferrari, G, Salvatori, G., Rossi, C., Cossu, G., and Mavilio, F., (1995), A retroviral vector containing a musclespecific enhancer drives gene expression only in differentiated muscle fibers, Hum Gene Ther6:733–742.
Finer, M.H., Dull, T.J., Qin, L., Farson, D, and Roberts, M.R., (1994), kat: a high-efficiency retroviral transduction system for primary human T lymphocytes, Blood83:43–50.
Ghattas, I.R., Sanes, J.R., and Majors, J.E., (1991), The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos, Mol Cell Biol11:5848–5859.
Gossen, M., and Bujard, H., (1992), Tight control of gene expression in mammalian cells by tetracyclineresponsive promoters, Proc Natl Acad Sci U S A89:5547–5551.
Günzburg, W.H., and Salmons, B., (1996), Retroviral Vectors, in Gene Therapy. (N.R. Limoine, and D.N. Cooper eds.) pp. 33–60, Oxford, BIOS Scientific Publishers Ltd.
Hantzopoulos, P.A., Sullenger, B.A., Ungers, G., and Gilboa, E., (1989), Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector, Proc Natl Acad Sci U S A86:3519–3523.
Hatzoglou, M., Hodgson, C.P., Mularo, F., and Hanson, R.W., (1990), Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses, Hum Gene Ther1:385–397.
Herniou, E., Martin, J., Miller, K.., Cook, J., Wilkinson, M., and Tristem, M., (1998), Retroviral diversity and distribution in vertebrates, J Virol72:5955–5966.
Hodgson, C.P., and Solaiman, F., (1996), Virosomes: cationic liposomes enhance retroviral transduction, Nat Biotechnol14:339–342.
Itin, A., and Keshet, E., (1983), Apparent recombinants between virus-like (VL30) and murine leukemia virusrelated sequences in mouse DNA, J Virol47:178–184.
Jiang, A., Chu, T.H.T., Nocken, F., Cichutek, K., and Dornburg, R., (1998), Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies, J Virol72:10148–10156.
Kavanaugh, M.P., Miller, D.G., Zhang, W., Law, W., Kozak, S.L., Rabat, D., and Miller, A.D., (1994), Cellsurface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters, Proc Natl Acad Sci U S A91:7071–7075.
Kirn, V.N., Mitrophanous, K., Kingsman, S.M., and Kingsman, A.J., (1998), Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1, J Virol72:811–816.
Landau, N.R., and Littman, D.R., (1992), Packaging system for rapid production of murine leukemia virus vectors with variable tropism, J Virol66:5110–5113.
Li, L.P., Schlag, P.M., and Blankenstein, T., (1997), Transient expression of SV 40 large T antigen by Cre/LoxPmediated site-specific deletion in primary human tumor cells, Hum Gene Ther8:1695–1700.
Linial, M., Medeiros, E., and Hayward, W.S., (1978), An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization, Cell15:1371–1381.
Mann, R., Mulligan, R.C., and Baltimore, D., (1983), Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell33:153–159.
Markowitz, D., Goff, S., and Bank, A., (1988), Construction and use of a safe and efficient amphotropic packaging cell line, Virology167:400–406.
Martin, F, Kupsch, J., Takeuchi, Y., Russell, S., Cosset, F.L., and Collins, M., (1998), Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope, Hum Gene Ther9:737–746.
Miller, A.D., (1997), Development and application of retroviral vectors, in Retroviruses (J.M. Coffin, S.H. Hughes, and H.E. Vermus eds.) pp. 437–474, Cold Spring Harbor Laboratory Press, New York.
Miller, A.D., and Buttimore, C., (1986), Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production, Mol Cell Biol6:2895–2902.
Miller, A.D., and Chen, F., (1996), Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry, J Virol70:5564–5571.
Miller, A.D., Garcia, J.V., von Suhr, N., Lynch, C.M., Wilson, C., and Eiden, M.V., (1991), Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus, J Virol65:2220–2224.
Miller, D.G., Adam, M.A., and Miller, A.D., (1990), Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection, Mol Cell Biol10:4239–4242.
Miller, D.G., and Miller, A.D., (1994), A family of retroviruses that utilize related phosphate transporters for cell entry, J Virol68:8270–8276.
Morgenstern, J.P., and Land, H., (1990), Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line, Nucleic Acids Res18:3587–3596.
Morling, F.J., Peng, K.W., Cosset, F.L., and Russell, S.J., (1997), Masking of retroviral envelope functions by oligomerizing polypeptide adaptors, Virology234:51–61.
Morling, F.J., and Russell, S.J., (1995), Enhanced transduction efficiency of retroviral vectors coprecipitated with calcium phosphate, Gene Ther2:504–508.
Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D., (1996), In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector, Science272:263–267.
Neda, H., Wu, C.H., and Wu, G.Y., (1991), Chemical modification of an ecotropic murine leukemia virus results in redirection of its target cell specificity, J Biol Chem266:14143–14146.
O’Hara, B., Johann, S.V., Klinger, H.P., Blair, D.G., Rubinson, H., Dunn, K.J., Sass, P., Vitek, S.M., and Robins, T., (1990), Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus, Cell Growth Differ1:119–127.
Olah, Z., Lehel, C., Anderson, W.B., Eiden, M.V., and Wilson, C.A., (1994), The cellular receptor for gibbon ape leukemia virus is a novel high affinity sodium-dependent phosphate transporter, J Biol Chem269:25426–25431.
Olsen, J.C., (1998), Gene transfer vectors derived from equine infectious anemia virus, Gene Therapy5:1481–1487.
Ory, D.S., Neugeboren, B.A., and Mulligan, R.C., (1996), A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes, Proc Natl Acad Sci U S A93:11400–11406.
Patience, C., Takeuchi, Y., Cosset, F.L., and Weiss, R.A., (1998), Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells, J Virol72:2671–2676.
Paulus, W., Baur, I., Boyce, F.M., Breakefield, X.O., and Reeves, S.A., (1996), Self-contained, tetracyclineregulated retroviral vector system for gene delivery to mammalian cells, J Virol70:62–67.
Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D., (1993), Production of high-titer helper-free retroviruses by transient transfection, Proc Natl Acad Sci U S A90:8392–8396.
Poeschla, E.M., Wong-Staal, F., and Looney, D.J., (1998), Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors, Nat Med4:354–357.
Porter, C.D., Lukacs, K.V., Box, G., Takeuchi, Y., and Collins, M.K., (1998), Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo, J Virol72:4832–4840.
Reiprich, S., Gundlach, B.R., Fleckenstein, B., and Uberla, K., (1997), Replication-competent chimeric lentioncovirus with expanded host cell tropism, J Virol71:3328–3331.
Rigg, R.J., Chen, J., Dando, J.S., Forestell, S.P., Plavec, I., and Bohnlein, E., (1996), A novel human amphotropic packaging cell line: high titer, complement resistance, and improvedsafety, Virology218:290–295.
Roth, J.A., and Cristiano, R.J., (1997), Gene therapy for cancer: what have we done and where are we going?, J Natl Cancer Inst89:21–39.
Rother, R.P., Fodor, W.L., Springhorn, J.P., Birks, C.W., Setter, E., Sandrin, M.S., Squinto, S.P., and Rollins, S.A., (1995), A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody, J Exp Med182:1345–1355.
Roux, P., Jeanteur, P., and Piechaczyk, M., (1989), A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses, Proc Natl Acad Sci U S A86:9079–9083.
Russ, A.P., Friedel, C., Ballas, K., Kalina, U., Zahn, D., Strebhardt, K., and von Melchner, H., (1996a), Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using genetrap mutagenesis and site-specific recombination, Proc Natl Acad Sci U S A93:15279–15284.
Russ, A.P., Friedel, C., Grez, M., and von Melchner, H., (1996b), Self-deleting retrovirus vectors for gene therapy, J Virol70:4927–4932.
Savard, N., Cosset, F.L., and Epstein, A.L., (1997), Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors, J Virol71:4111–4117.
Scadden, D.T., Fuller, B., and Cunningham, J.M., (1990), Human cells infected with retrovirus vectors acquire an endogenous murine provirus, J Virol64:424–427.
Snitkovsky, S., and Young, J.A., (1998), Cell-specific viral targeting mediated by a soluble retroviral receptorligand fusion protein, Proc Natl Acad Sci U S A95:7063–7068.
Soneoka, Y., Cannon, P.M., Ramsdale, E.E., Griffiths, J.C., Romano, G., Kingsman, S.M., and Kingsman, A.J., (1995), A transient three-plasmid expression system for the production of high titer retroviral vectors, Nucleic Acids Res23:628–633.
Takahara, Y., Hamada, K., and Housman, D.E., (1992), A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes, J Virol66:3725–3732.
Takeuchi, Y., Cosset, F.L., Lachmann, P.J., Okada, H., Weiss, R.A., and Collins, M.K., (1994), Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell, J Virol68:8001–8007.
Takeuchi, Y., Liong, S.H., Bieniasz, P.O., Jager, U., Porter, C.D., Friedman, T., McClure, M.O., and Weiss, R.A., (1997), Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alphal-3) galactosylation, J Virol71:6174–4178.
Takeuchi, Y., Porter, C.D., Strahan, K.M., Preece, A.F., Gustafsson, K., Cosset, F.L., Weiss, R.A., and Collins, M.K., (1996), Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase, Nature379:85–88.
Valsesia Wittmann, S., Morling, F.J., Hatziioannou, T., Russell, S.J., and Cosset, F.L., (1997), Receptor cooperation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding, Embo J16:1214–1223.
Valsesia Wittmann, S., Morling, F.J., Nilson, B.H., Takeuchi, Y., Russell, S.J., and Cosset, F.L., (1996), Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU, J Virol70:2059–2064.
van Zeijl, M., Johann, S.V., Closs, E., Cunningham, J., Eddy, R., Shows, T.B., and O’Hara, B., (1994), A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family, Proc Natl Acad Sci U S A91: 1168–1172.
Vile, R.G., Diaz, R.M., Miller, N., Mitchell, S., Tuszyanski, A., and Russell, S.J., (1995), Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter, Virology214:307–313.
Vogt, V.M., (1997), Retroviral virions and genomes, in Retroviruses (J.M. Coffin, S.H. Hughes, and H.E. Vermus eds.) pp. 27–70, Cold Spring Harbor Laboratory Press, New York.
Watanabe, S., and Temin, H.M., (1983), Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors, Mol Cell Biol3:2241–2249.
Weiss, R.A., Boettiger, D., and Murphy, H.M., (1977), Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus, Virology76:808–825.
Welsh, R.M., Jr., Cooper, N.R., Jensen, F.C., and Oldstone, M.B., (1975), Human serum lyses RNA tumour viruses, Nature257:612–614.
Welsh, R.M., Jr., Jensen, F.C., Cooper, N.R., and Oldstone, M.B., (1976), Inactivation of lysis of oncornaviruses by human serum, Virology74:432–440.
Westerman, K.A., and Leboulch, P., (1996), Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination, Proc Natl Acad Sci U S A93:8971–8976.
Wilson, C.A., Ng, T.H., and Miller, A.E., (1997), Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors, Hum Gene Ther8:869–874.
Yang, Y., Vanin, E.F., Whitt, M.A., Fornerod, M., Zwart, R., Schneiderman, R.D., Grosveld, G., and Nienhuis, A.W, (1995), Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein, Hum Gene Ther6:1203–1213.
Yee, J.K., Miyanohara, A., LaPorte, P., Bouic, K., Burns, J.C., and Friedmann, T., (1994), A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes, Proc Natl Acad Sci U S A91:9564–9568.
Yu, S.F., von Ruden, T., Kantoff, P.W., Garber, C., Seiberg, M., Ruther, U., Anderson, W.F., Wagner, E.F., and Gilboa, E., (1986), Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells, Proc Natl Acad Sci U S A83:3194–3198.
Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L., and Trono, D., (1997), Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nat Biotechnol15:871–875.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Takeuchi, Y., Pizzato, M. (2002). Retrovirus Vectors. In: Habib, N.A. (eds) Cancer Gene Therapy. Advances in Experimental Medicine and Biology, vol 465. Springer, New York, NY. https://doi.org/10.1007/0-306-46817-4_3
Download citation
DOI: https://doi.org/10.1007/0-306-46817-4_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-306-46191-0
Online ISBN: 978-0-306-46817-9
eBook Packages: Springer Book Archive